Lannett announced that it has received approval from the Food and Drug Administration to market its version of a hypertension treatment.
Mylan said its subsidiary has launched a generic version of a hypertension treatment.
Gilead on Friday announced that the Food and Drug Administration has removed a boxed warning about a possible liver injury risk caused by the drug maker's hypertension treatment.
Drug maker Takeda has filed for regulatory approval of a drug to treat hypertension, the company said Wednesday.
The Food and Drug Administration has approved a generic hypertension treatment made by Mylan.
Mylan subsidiary Mylan Technologies has received final approval from the Food and Drug Administration for...